Le Lézard
Classified in: Health
Subject: SVY

Visiongain Launches Report Examining the Potential in the $1,447 bn Pharma Wholesale and Distribution Market


LONDON, Nov. 18, 2019 /PRNewswire/ -- The pharma wholesale and distribution market is estimated to grow at a CAGR of 5% in the first half of the forecast period. The market is estimated to reach a revenue of $1,447bn in 2025. In 2018, the branded drugs submarket held 78% of the pharma wholesale and distribution market.

Visiongain Logo

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 217-page report you will receive 135 charts? all unavailable elsewhere.

The 217-page Visiongain report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/pharma-wholesale-and-distribution-market-forecasts-2020-2030/#download_sampe_div

Report Scope

? Global Pharma Wholesale and Distribution Market from 2020-2030

? Forecast of the Global Pharma Wholesale and Distribution market by Category:
? Generic Drugs
? Branded Drugs
? Others

? This report provides individual revenue forecasts to 2030 for these national markets:
? US
? Germany
? France
? Italy
? Spain
? UK
? Japan
? China
? Brazil
? India
? Russia
? RoW

Each National Market is further segmented into generic drugs, branded drugs and others

? Our study discusses the selected leading companies that are the major players in the global pharma and wholesale distribution market:
? Alfresa Holdings
? AmerisourceBergen
? Cardinal Health
? CR Pharmaceuticals
? CuraScript SD
? McKesson
? Medipal Holdings Corporation
? Morris and Dickson
? Mutual Drug Company
? PHOENIX Group
? Shanghai Fosun Pharmaceuticals
? Sinopharm
? Suzuken
? Walgreens Boots Alliance

? This report provides a SWOT and STEP analysis of the pharma wholesale and distribution market.

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/pharma-wholesale-and-distribution-market-forecasts-2020-2030/

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Companies covered in the report include:

36.6
AAH Pharmaceuticals
AccessClosure
Acofarma (Asociación Cooperativas Farmacéuticas)
ADG Apotheken-Dienstleistungsgesellschaft mbH
Admenta
Alfresa Fine Chemical Corporation
Alfresa Holdings
Alliance Boots
Alliance Healthcare
Alliance Santé
Alliance UniChem
AmeriSource Health
AmerisourceBergen
AmerisourceBergen Canada
AmerisourceBergen Drug Corporation (ABDC)
AmerisourceBergen specialty Group (ABSG)
Apollo Medical Holdings
ASTEC Co., Ltd.
ASTIS Co., Ltd.
Athos Farma
ATOL CO., LTD.
Azwell
Bayer
BENU Apotheek
Bergen Brunswig
Biologics Inc
Boots Group
Bristol-Myers Squibb
Brocacef Groep NV
Brocacef Holding
Bundesverband des Pharmazeutischen Grosshandel
Cardinal Health
Caremark Rx
Celesio AG
CERP Bretagne Nord
CERP Rhin Rhone Mediterranee
CERP Rouen
Chiyaku Co
Chuounyu Co., Ltd.
Cloumed Corporation
Cofares
Comifar
Cordis
CoverMyMeds
CoverMyMeds LLC
CVS Caremark
CVS Corporation
CVS Health Corporation
Cystic Fibrosis Foundation Pharmacy, LLC
Daiichi Sankyo Propharma Co.
Dong Ying (Jiangsu) Pharmaceuticals Co., Ltd.
Drogarias Tamoio
Drug Trading Company Ltd
Dutch ACM
Emart Company
ENSHU YAKUHIN CO., LTD.
Ethicon
EVERLTH AGROTECH Co., Ltd.
EVERLTH Co., Ltd.
Farcopa Distribuzione
Fukujin Co.
Good Service Co
Guangzhou Pharmaceutical Company Ltd.
Guangzhou Pharmaceuticals Corporation
Harvard Drug
Hedef Alliance
Hefame
HEISEI YAKUHIN CO., LTD.
IZUTSU KURAYA SANSEIDO Inc.
IZUTSU PHARMACEUTICAL CO. LTD.
Japanese Pharmaceutical Wholesalers Association
Jingu Yakuhin Co., Ltd.
Johnson & Johnson
Katren
Kenzmedico Co., Ltd.
Kerr Drug
KOBASHOU. CO., LTD.
KURAYA SANSEIDO Inc
Life Medicom Co., Ltd.
Lloyds Pharmacy
MARUZEN YAKUHIN CO., LTD.
McKesson
McQueary Brothers of Springfield
Medical Specialties Distributors
MEDICEO CORPORATION
Medicine Shoppe Canada Inc.
MEDIE Co., Ltd.
MEDIPAL HOLDINGS CORPORATION
Mediq Apotheken Nederland B.V.
Medtronic
Meinan Distribution Center
Metro Medical Supply Inc
Mitsubishi
MM CORPORATION
MP AGRO CO., LTD.
MVC CO., LTD
MWI Veterinary Supply, Inc.
Nadro
Nakano Yakuhin Co., Ltd.
National Health Service (NHS)
National Pharmaceutical Pricing Authority (NPPA)
Nihon Apoch Co.
Novo Nordisk
Novodata Zrt.
Numark
OCP
Oncology Therapeutics
Oncoprod
OptumRx
P.J.D. Network
PALTAC CORPORATION
Paltac Corporation
Paltac Corporation
PALTAC KS CORPORATION
Panpharma
Pfercos Co., Ltd.
Pfizer
PharMEDium
Polska Grupa Farmaceutyczna
Profarma
Prosper
Protek
PSC Co, Ltd.
PSS World Medical Inc.
Ratiopharm
RDC Kanto5
Red Oak Sourcing
Red Oak, LLC
Rexall Health
Rite Aid Corporation
Rosta
RxCrossroads
S. D.Collabo Co.,Ltd.
S.D.Logi CO., Ltd.
Sakurai Tsusho Corporation
Sanacorp
Sandoz
Sanki Corporation
Sanki MediHeart Limited
Sanki Wellbe
Sanki Wellbe Co., Ltd.
Sannova
Sanwa Kagaku Kenkyusho Co., Ltd.
S-Care Mate Co., Ltd.
Sciclone Trade
SEIWA SANGYO CO
Shanghai Fosun Pharmaceutical
Shanghai Pharma Zhenjiang Co., Ltd.
Shanghai Pharmaceutical Holdings
Shinohara Chemicals
Shinsegai Group
Shoyaku Co., Ltd.
SIA International
Sincamesp
SINOPHARM
S-mile, Inc
Sonexus Health
SPH Jiangxi Shangrao Pharmaceutical Co., Ltd.
SPH Keyuan Xinhai Pharmaceutical Hebei Co., Ltd.
SPH Keyuan Xinhai Pharmaceutical Heilongjiang Co., Ltd.
SPLine Corporation
SUZUKEN
Suzuken Co., Ltd.
Suzuken Iwate Co., Ltd.
Suzuken Medical Instruments Co, Ltd
Suzuken Okinawa Yakuhin Co., Ltd.
The PHOENIX Group
Toho Holdings
Tokiwa Yakuhin Co
Torfarm
Tradex International
TS Alfresa Corporation
UniChem
US Oncology Holdings, Inc.
USHIODA KURAYA SANSEIDO Inc.
USHIODA SANGOKUDO YAKUHIN CO., LTD.
Vaccine Safe Co
Vantage Oncology
Victoria Merger Sub, Inc.
Vitaco Holdings
Walgreen
Walgreens Boots Alliance
World Courier Group Inc.
Wyeth Pharmaceuticals
YAMAHIRO KURAYA SANSEIDO Inc.
Yunnan Pharmaceutical Co., Ltd.
Zuellig Pharma

To see a report overview please e-mail Sara Peerun on [email protected]

Related reports:

Anti-infective Agents Market Forecast 2019-2029

Advanced Wound Care Market Forecast 2019-2029

Biologics Market Trends and Forecasts 2019-2029

Global Macular Degeneration (AMD) and Other Retinal Diseases Drugs Industry and Market 2019-2029

Global Rare Disease Drugs Market Forecast 2019-2029

Global OTC Pharmaceutical Market Forecast 2019-2029

Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg


These press releases may also interest you

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...



News published on and distributed by: